Qiagen N.V. has grown revenue −0.81% a year over three years and 2.3% a year over five, with earnings per share compounding at 1.8%. Revenue growth, 3-year annual rate: −0.81% (Diagnostics & Research median +9.1%). Revenue growth, 5-year rate: +2.3%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +1.8%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 18, FY2008 to FY2025, as filed.

QGENQiagen N.V.

HealthcareUSD

$43.35

$32.6352 weeks$55.66

Is it growing?

Is QGEN growing?

Qiagen N.V. has grown revenue −0.81% a year over three years and 2.3% a year over five, with earnings per share compounding at 1.8%.

−0.81%

Revenue growth, 3-year annual rate · Diagnostics & Research median +9.1% · shrinking · compounded from fiscal years as filed

Revenue growth, 5-year rate: +2.3%
Revenue growth, 5-year rate · −0.81% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +1.8%
Earnings per share, 3-year rate · revenue −0.81% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 18
Years of annual history on file · FY2008 to FY2025, as filed